Carbapenem-Resistant GNB Infections Treatment
32 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What was the primary objective of the meta-analysis?

  • To compare the efficacy of colistin monotherapy and colistin-based combination therapy for treating carbapenem-resistant gram-negative bacteria infections (correct)
  • To examine the nephrotoxicity of colistin alone versus colistin in combination with other therapies
  • To evaluate the potential synergistic effects of combining colistin with various antibiotics
  • To determine the optimal dosage of colistin for treating infections caused by carbapenem-resistant Acinetobacter baumannii

What was the total number of patients included in the five randomized controlled trials?

  • 1011
  • 1201
  • 501
  • 791 (correct)

What was the outcome of the subgroup analysis regarding high or low dosage of colistin?

  • A significant difference was found in infection-related mortality
  • No significant difference was found in infection-related mortality or microbiologic response (correct)
  • A notable disparity was revealed in microbiologic response
  • A significant increase in nephrotoxicity was observed

What is the current preference for treating Acinetobacter strains that have developed resistance to carbapenems?

<p>Colistin-based combination treatments (C)</p> Signup and view all the answers

What was the primary concern that led to the preference for colistin-based combination treatments over colistin monotherapy?

<p>Nephrotoxicity (D)</p> Signup and view all the answers

What is the primary goal of the research examining the combination of colistin with other antibiotics?

<p>To evaluate the potential synergistic effects of combining colistin with other antibiotics (A)</p> Signup and view all the answers

What percentage of strains exhibited synergistic effect between colistin and vancomycin?

<p>17.4% (D)</p> Signup and view all the answers

Which antibiotic combination did not exhibit noticeable synergistic activity?

<p>Colistin and tigecycline (A)</p> Signup and view all the answers

What percentage of strains showed synergistic inhibition when treated with a combination of colistin and meropenem at 24 hours after treatment?

<p>100% (C)</p> Signup and view all the answers

What was the minimum inhibitory concentration (MIC) of meropenem above which the effectiveness of colistin was not substantially affected?

<p>64 mg/L (C)</p> Signup and view all the answers

According to the IDSA guidelines, what is the recommended approach when treatment must be prolonged for an extended period of time?

<p>Switch to a single active medication (D)</p> Signup and view all the answers

What percentage of studies examining the efficacy of combination therapy for the treatment of CRAB infections revealed a possible advantage for this approach?

<p>12.5% (C)</p> Signup and view all the answers

What was the dosage of meropenem administered in the first study comparing colistin monotherapy to colistin and meropenem?

<p>2 grams intravenously every 8 hours (A)</p> Signup and view all the answers

What was the 28-day mortality rate in the group receiving colistin alone in the first study?

<p>46% (A)</p> Signup and view all the answers

What is the percentage of strains that demonstrated bactericidal action against colistin 48 hours after treatment?

<p>91.7% (A)</p> Signup and view all the answers

What is the name of the guidelines that state that combination therapy enhances the eradication of pathogens?

<p>IDSA Guidelines (C)</p> Signup and view all the answers

What was the 28-day mortality rate in the colistin monotherapy arm?

<p>46% (D)</p> Signup and view all the answers

What was the clinical response rate in the meropenem/colistin group after 28 days?

<p>75% (C)</p> Signup and view all the answers

What percentage of patients showed clinical improvement on day five in the colistin group?

<p>16% (B)</p> Signup and view all the answers

How many articles compared the efficacy of a single treatment to that of a combination of therapies?

<p>29 (B)</p> Signup and view all the answers

What was the primary composite outcome assessed in the AIDA randomized controlled trial?

<p>Clinical failure at day 14 and mortality within 14 days (A)</p> Signup and view all the answers

How many patients were diagnosed with carbapenem-resistant Acinetobacter baumannii (CRAB) bacteraemia, ventilator-associated pneumonia (VAP), or hospital-acquired pneumonia in the AIDA trial?

<p>312 (B)</p> Signup and view all the answers

What was the total daily dosage of the sulbactam component in the seventh investigation?

<p>6 grams (D)</p> Signup and view all the answers

What is a proposed benefit of combination therapy for CRAB infections?

<p>Increasing the likelihood of administering at least one active agent (C)</p> Signup and view all the answers

How many randomized controlled trials (RCTs) compared the efficacy of a single treatment to that of a combination of therapies?

<p>6 (B)</p> Signup and view all the answers

What is a limitation of the observational studies evaluating CRAB treatment?

<p>Low certainty (C)</p> Signup and view all the answers

What is the typical minimum inhibitory concentration (MIC) of Acinetobacter baumannii when it acquires carbapenem resistance?

<p>Above 16 mg/L (B)</p> Signup and view all the answers

What is the recommended administration method for carbapenem combination treatments?

<p>Prolonged or continuous infusion (C)</p> Signup and view all the answers

What was the conclusion of the three randomized controlled trials (RCTs) evaluating the efficacy of combining colistin and rifampin?

<p>There is no superiority of colistin-rifampin combination treatment over colistin monotherapy (B)</p> Signup and view all the answers

What is the recommendation for patients with CRAB infections with a meropenem MIC?

<p>Combination therapy including two in vitro active antibiotics (D)</p> Signup and view all the answers

What is the conclusion regarding the use of double covering combo therapy for CRAB?

<p>There are few and inconclusive data to support the use of double covering combo therapy (A)</p> Signup and view all the answers

What is the general suggestion for treating CRAB infections?

<p>Combination therapy with at least two active agents (D)</p> Signup and view all the answers

More Like This

Antimicrobial Therapy Overview
24 questions
Use Quizgecko on...
Browser
Browser